Inhibitory Control Tells Only Part of the Story: Reward Sensitivity Moderates the Prospective Link Between the No‐Go P3 and Emerging Eating Pathology in Early Adolescents
International Journal of Eating Disorders · 2026-11 · 59 (11) · 2486-2497
DOI: 10.1002/eat.70172 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Eating Disorders, online erschienen am 09.07.2026. Verfasst von Jaron X Y Tan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Inhibition, Psychological, Reward, Feeding and Eating Disorders, Event-Related Potentials, P300. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Women and Children's Health Research Institute, NIGMS Centers of Biomedical Research Excellence.
Abstract (Originalsprache)
Objective
Early adolescence is characterized by the onset of mental health problems, including eating pathology (e.g., body image concerns, restrictive eating). Inhibitory control (IC) and reward sensitivity (RS) are two key traits that have been implicated in the development of eating problems. IC is defined as the ability to suppress a prepotent response to facilitate goal‐directed behavior; RS refers to individuals' responsivity to reward‐related stimuli (e.g., food). Despite growing research on IC and RS, little work has examined their joint contribution in predicting emerging eating problems in early adolescents. Further, no work has examined how neurophysiological correlates of IC, like the P3 component, interact with RS to predict subsequent eating pathology.
Method
We analyzed two waves of data from 63 healthy early adolescents (39 girls; Mean age/SD at T1 = 11.01/1.18 years), collected approximately 1 year apart. Youths completed an EEG Go/No‐Go task and reported on their eating problems at T1 and T2; they also reported on their RS at T1.
Results
We found a moderating effect of RS on the association between the No‐Go P3 and disordered eating symptoms: controlling for T1 disordered eating symptoms, a smaller No‐Go P3 at T1 predicted greater disordered eating symptoms at T2, specifically for those with higher RS at T1. Contrary to our expectations, higher, but not lower, commission errors at T1 predicted lower disordered eating symptoms at T2.
Discussion
We contribute novel evidence on the moderating effect of RS on the prospective association between IC and eating pathology in early adolescence. Future studies can leverage these findings to inform IC‐related preventions for youths at risk for eating problems, particularly those with heightened RS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Jaron X Y Tan, Lisa Brooks, Pan Liu
Förderung
- NIGMS NIH HHS
- Women and Children's Health Research Institute
- NIGMS Centers of Biomedical Research Excellence
Zitieren
APA
Tan, J. X. Y., Brooks, L., & Liu, P. (2026). Inhibitory Control Tells Only Part of the Story: Reward Sensitivity Moderates the Prospective Link Between the No‐Go P3 and Emerging Eating Pathology in Early Adolescents. International Journal of Eating Disorders, 59(11), 2486-2497. https://doi.org/10.1002/eat.70172
Vancouver
Tan JXY, Brooks L, Liu P. Inhibitory Control Tells Only Part of the Story: Reward Sensitivity Moderates the Prospective Link Between the No‐Go P3 and Emerging Eating Pathology in Early Adolescents. International Journal of Eating Disorders. 2026;59(11):2486-2497. doi:10.1002/eat.70172
BibTeX
@article{Tan2026,
author = {Tan, Jaron X Y and Brooks, Lisa and Liu, Pan},
title = {Inhibitory Control Tells Only Part of the Story: Reward Sensitivity Moderates the Prospective Link Between the No‐Go P3 and Emerging Eating Pathology in Early Adolescents},
journal = {International Journal of Eating Disorders},
year = {2026},
volume = {59},
number = {11},
pages = {2486--2497},
doi = {10.1002/eat.70172}
}
EUVIMED